A practical reference on NMN: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-04 and is reviewed periodically as new material appears.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Two enzymatic steps define the canonical route from nicotinamide to NAD+. Nicotinamide phosphoribosyltransferase, known as NAMPT, produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN adenylyltransferases, or NMNAT enzymes, then couple NMN with ATP to form NAD+. Whether intact NMN crosses cell membranes efficiently remains an active area of investigation; some studies propose direct transport, while others emphasize extracellular dephosphorylation to nicotinamide riboside followed by uptake. The relative contribution of each route likely depends on cell type, tissue, and experimental conditions.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms, including bacteria, plants, and mammals. Its structure consists of a nicotinamide ring attached to a ribose-phosphate group. NMN functions as an intermediate in the NAD+ salvage pathway, a recycling route that regenerates nicotinamide adenine dinucleotide. The enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+.
Dietary sources of NMN include small amounts in certain vegetables, fruits, and other foods, although exact values vary by sample and method. Endogenous NMN concentrations are tightly regulated and often low, making measurement in blood or tissues technically demanding. After oral intake, NMN is thought to be rapidly metabolized in the intestine and liver, and intact NMN may not reach all tissues at high levels. Some rodent studies report increases in tissue NAD+ after oral NMN, while human data remain limited and sometimes rely on blood NAD+ metabolites rather than direct tissue measures.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C11H15N2O8P | Canonical beta anomer; charge state depends on pH. |
| Molar mass | 334.22 g/mol | Calculated for the neutral formula. |
| CAS Registry Number | 1094-61-7 | Common identifier for beta-nicotinamide mononucleotide. |
| Appearance | White to off-white powder or crystals | Varies with purity, hydration, and polymorphism. |
| Solubility | Freely soluble in water; low solubility in nonpolar solvents | Reported values depend on salt form and temperature. |
Nicotinamide mononucleotide, commonly abbreviated NMN, is a pyridine nucleotide that consists of a nicotinamide ring, a ribose sugar, and a phosphate group. It is an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+, synthesis. In mammalian cells, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. Nicotinamide mononucleotide adenylyltransferases then convert NMN into NAD+. The core structure and enzymatic route are well established in biochemical literature.
The biologically relevant form of NMN is generally the beta anomer, which is recognized by NMN adenylyltransferases. NMN is polar and water soluble, and it does not readily diffuse across lipid membranes without assistance. Whether intact NMN enters cells through a specific transporter remains an open question; some studies propose solute carrier family members, while other work favors extracellular dephosphorylation to nicotinamide riboside followed by uptake. This transport and compartmentalization debate affects how researchers interpret oral administration studies. The distinction between intracellular synthesis and extracellular delivery is central to current discussion.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
=== Demenz === Studien zeigen einen Zusammenhang zwischen hohen Cholesterinwerten während der Lebensmitte und der späteren Entwicklung von Demenz. In einer Studie mit 2125 Teilnehmern wurde ein Zusammenhang zwischen hohen LDL-Cholesterin und frühem Einsetzen von Alzheimer gefunden.
=== Einfluss der Ernährung auf den Cholesterinspiegel === Eine hohe Zufuhr von gesättigten Fettsäuren erhöht sowohl die Gesamt- als auch die LDL-Cholesterinkonzentration im Blut. Die Deutsche Gesellschaft für Ernährung empfiehlt daher, die Zufuhr an gesättigten Fetten auf 7 % bis 10 % der täglich aufgenommenen Nahrungsenergie zu beschränken. Die WHO empfiehlt zur Reduktion des LDL-Spiegels und somit zur Vorbeugung kardiovaskulärer Erkrankungen ebenfalls, den Konsum gesättigter Fette auf unter 10 % zu beschränken. Die Zufuhr von Nahrungscholesterin – hauptsächlich in tierischen Lebensmitteln enthalten – führt wahrscheinlich zu einem Anstieg des Verhältnisses von Gesamt- zu HDL-Cholesterin und mit überzeugender Evidenz zu einem geringen Anstieg von Gesamt- und LDL-Cholesterin. Die National Academies of Sciences, Engineering, and Medicine empfehlen, die trans-Fettsäuren- und Cholesterinaufnahme so niedrig wie möglich zu halten, ohne dabei die adäquate Nährstoffversorgung zu gefährden. Die meisten tierischen Lebensmittel enthalten sowohl Cholesterin als auch gesättigte Fette. In jüngerer Zeit wird argumentiert, dass die wenigen tierischen Lebensmittel, die zwar viel Cholesterin, aber wenig gesättigte Fette enthalten (Eier, Garnelen), keinen negativen Einfluss auf die Herzkreislaufgesundheit haben. So lässt der Konsum von Eiern für geschätzt 70 % der Menschen den Cholesterinspiegel kaum ansteigen.
Bei Personen, bei denen Eierkonsum zu einem Anstieg des Gesamtcholesterinspiegels führt, steigen sowohl der LDL- als auch der HDL-Spiegel, was erklären könnte, warum Eier bislang in Beobachtungsstudien nicht eindeutig mit einem erhöhten Risiko für Herzkreislauferkrankungen assoziiert sind. Um die gesundheitlichen Aspekte des Eierkonsums abschließend zu bewerten, sieht die Deutsche Gesellschaft für Ernährung noch Forschungsbedarf in Form von Interventionsstudien.
Sources: de.wikipedia.org
=== Empfehlung bei hohem Cholesterinspiegel === Nach einer Diagnose eines hohen Cholesterinspiegels wird in der Regel als erste Maßnahme eine fettmodifizierte und cholesterinarme Ernährung empfohlen. Eine umfassende Darstellung zu dieser Frage wurde 1981 vom Institut für Sozialmedizin und Epidemiologie des Bundesgesundheitsamts veröffentlicht. Gemäß den Empfehlungen der DGFF (Lipid-Liga) sollten hierbei folgende Punkte bei der Nahrungsaufnahme bedacht werden:
Sources: de.wikipedia.org
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ metabolism. It occurs naturally in cells and can also be produced synthetically for research or commercial use. Its name reflects its composition: nicotinamide, ribose, and a phosphate group.
NMN is a direct precursor in the NAD+ salvage pathway. NMNAT enzymes convert NMN and ATP into NAD+, a coenzyme used in many cellular reactions. This relationship makes NMN a focus of studies on NAD+ metabolism.
Small amounts of NMN have been reported in some plant foods, but measured levels vary and are not consistently quantified. Dietary contribution is generally considered minor compared with endogenous production. Food-matrix effects make accurate analysis difficult.
NMN is nicotinamide mononucleotide, a nucleotide intermediate in the NAD+ salvage pathway. Cells use it to help regenerate NAD+, a coenzyme involved in energy metabolism and cellular signaling. It is present naturally in many organisms and is also produced synthetically for research and consumer products.